Lenvatinib promotes antitumor immunity by enhancing the tumor infiltration and activation of NK cells

Based on previous reports, the efficacy of lenvatinib against cancer is mainly attributed to its antiangiogenic activity and its ability to suppress tumor proliferation, which are mediated by targeting receptor tyrosine kinases (RTKs). However, the effects of lenvatinib on tumor immune modulation ha...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Zhang, Qing, Liu, Hongyan, Wang, Hanhan, Lu, Mengmeng, Miao, Yangna, Ding, Jiage, Li, Huizhong, Gao, Xiaoge, Sun, Shishuo, Zheng, Junnian
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6682710/
https://ncbi.nlm.nih.gov/pubmed/31392076
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars